CANTALOUPE HAZE

Brand Owner (click to sort) Address Description
CANNALOPE HAZE OG DNA GENETICS INC. Suite 400 444 West C Street San Diego CA 92101 CANTALOUPE HAZE;Clothing, namely, men's athletic shirts, polo shirts, shirts, long sleeve shirts, short sleeve shirts, sport shirts, sweat shirts, sweaters, t-shirts, long sleeve t-shirts, short sleeve t-shirts, shorts, pants, sweat pants, hooded sweat shirts, athletic headbands and wristbands, sports jerseys, sleeveless tops, tank tops, footwear, namely, socks, flip flops, sandals, slides, shoes and sneakers, headwear, namely, hats and beanies, and face coverings in the nature of knit face masks; Clothing, namely, women's athletic shirts, polo shirts, shirts, long sleeve shirts, short sleeve shirts, sport shirts, sweat shirts, sweaters, t-shirts, long sleeve t-shirts, short sleeve t-shirts, shorts, pants, sweat pants, hooded sweat shirts, athletic headbands and wristbands, sports jerseys, sleeveless tops, tank tops, footwear, namely, socks, flip flops, sandals, slides, shoes and sneakers, headwear, namely, hats and beanies, and face coverings in the nature of knit face masks; Clothing, namely, cloth bibs; clothing for babies, toddlers and children, namely, pajamas, jackets, shirts, pants, jumpers, t-shirts, tops, athletic headbands and wristbands, face coverings in the nature of knit face masks, sports jerseys, sleeveless tops, tank tops; Headwear for children and babies; Footwear for children and babies, namely, shoes, sneakers, socks, flip flops, sandals and slides;
CANNALOPE HAZE OG DNA GENETICS INC. Suite 400 444 West C Street San Diego CA 92101 CANTALOUPE HAZE;Natural flowers, agricultural seeds; the aforementioned solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;
CANNALOPE HAZE OG DNA GENETICS INC. Suite 400 444 West C Street San Diego CA 92101 CANTALOUPE HAZE;Smoker's articles, namely, lighters;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.